BACKGROUND: Immunocompromised patients with influenza are at higher risk of pneumonia and death. However, risk factors for progression to pneumonia still need evaluation. METHODS: Retrospective study in immunocompromised patients with influenza-related respiratory infections. Risk factors for pneumonia were identified by multivariable logistic regression. RESULTS: We identified 100 immunocompromised patients infected with influenza (68 hematological malignancies, 11 HIV, 21 iatrogenic immunosuppression). Immunofluorescence was positive in 95% of patients, mainly on nasopharyngeal aspirates (84%). Influenza A virus was involved in 80% of patients. Associated infection was documented in 34 patients. All patients presented with upper respiratory tract infection and 53 progressed to pneumonia. Thirty-two patients were critically ill, 11 received mechanical ventilation, and 10 died. All the patients who died had pneumonia. Patients with pneumonia were older (46y (36-63) vs. 33y (13-51), P=0.003) and more often had influenza A (89% vs. 70%, P=0.04) and associated infection (56% vs. 9%, P<0.0001). Factors independently associated with progression to pneumonia were influenza A (OR 5.54, 95% CI [1.16-26.47]) and hematological malignancies (OR 3.85, 95% CI [1.1-14.5]). CONCLUSIONS: In our cohort of hospitalized immunocompromised patients, influenza progresses to pneumonia in more than half the patients. Patients with hematological malignancies and influenza A infection are at higher risk for pneumonia and should be included in preemptive antiviral therapy trials. Copyright 2010 Elsevier Ltd. All rights reserved.
BACKGROUND: Immunocompromised patients with influenza are at higher risk of pneumonia and death. However, risk factors for progression to pneumonia still need evaluation. METHODS: Retrospective study in immunocompromised patients with influenza-related respiratory infections. Risk factors for pneumonia were identified by multivariable logistic regression. RESULTS: We identified 100 immunocompromised patients infected with influenza (68 hematological malignancies, 11 HIV, 21 iatrogenic immunosuppression). Immunofluorescence was positive in 95% of patients, mainly on nasopharyngeal aspirates (84%). Influenza A virus was involved in 80% of patients. Associated infection was documented in 34 patients. All patients presented with upper respiratory tract infection and 53 progressed to pneumonia. Thirty-two patients were critically ill, 11 received mechanical ventilation, and 10 died. All the patients who died had pneumonia. Patients with pneumonia were older (46y (36-63) vs. 33y (13-51), P=0.003) and more often had influenza A (89% vs. 70%, P=0.04) and associated infection (56% vs. 9%, P<0.0001). Factors independently associated with progression to pneumonia were influenza A (OR 5.54, 95% CI [1.16-26.47]) and hematological malignancies (OR 3.85, 95% CI [1.1-14.5]). CONCLUSIONS: In our cohort of hospitalized immunocompromised patients, influenza progresses to pneumonia in more than half the patients. Patients with hematological malignancies and influenza A infection are at higher risk for pneumonia and should be included in preemptive antiviral therapy trials. Copyright 2010 Elsevier Ltd. All rights reserved.
Authors: Brandon H Hayes; Dana L Haberling; Jordan L Kennedy; Jay K Varma; Alicia M Fry; Neil M Vora Journal: Chest Date: 2017-10-07 Impact factor: 9.410
Authors: B Hermann; N Lehners; M Brodhun; K Boden; A Hochhaus; M Kochanek; K Meckel; K Mayer; T Rachow; C Rieger; E Schalk; T Weber; A Schmeier-Jürchott; P Schlattmann; D Teschner; M von Lilienfeld-Toal Journal: Eur J Clin Microbiol Infect Dis Date: 2016-11-12 Impact factor: 3.267
Authors: E Cordero; T Aydillo; M C Fariñas; J R Paño-Pardo; J Pachón; D Viasus; M Riera; F López-Medrano; A Payeras; A Moreno; J Rodríguez-Baño; J A Oteo; J Martínez-Montauti; J Torre-Cisneros; F Segura; J Carratalá Journal: Eur J Clin Microbiol Infect Dis Date: 2011-07-27 Impact factor: 3.267
Authors: Marie von Lilienfeld-Toal; Annemarie Berger; Maximilian Christopeit; Marcus Hentrich; Claus Peter Heussel; Jana Kalkreuth; Michael Klein; Matthias Kochanek; Olaf Penack; Elke Hauf; Christina Rieger; Gerda Silling; Maria Vehreschild; Thomas Weber; Hans-Heinrich Wolf; Nicola Lehners; Enrico Schalk; Karin Mayer Journal: Eur J Cancer Date: 2016-09-25 Impact factor: 9.162